This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know [Yahoo! Finance]
CG Oncology, Inc. (CGON)
Company Research
Source: Yahoo! Finance
1,059,375 shares in the fourth quarter for an estimated $43.84 million based on quarterly average pricing, according to a February 17, 2026, SEC filing. What happened According to a filing with the Securities and Exchange Commission dated February 17, 2026, Kynam Capital Management sold 1,059,375 shares of CG Oncology during the fourth quarter. The estimated transaction value was $43.84 million, calculated using the period's average closing price. After the sale, the fund held 945,830 shares, valued at $39.27 million at quarter-end. The net position change, reflecting both trading and price effects, was $41.50 million. What else to know The reduction brings CG Oncology to 2.51% of Kynam Capital's 13F reportable AUM, down from 6.0% the prior quarter. Top holdings after the filing: NASDAQ:COGT: $218.99 million (14.3% of AUM) NASDAQ:VERA: $173.85 million (11.3% of AUM) NASDAQ:SNDX: $169.15 million (11.0% of AUM) NASDAQ:CLDX: $161.42 million (10.5% of AUM) NASDAQ:PCVX:
Show less
Read more
Impact Snapshot
Event Time:
CGON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CGON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CGON alerts
High impacting CG Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
CGON
News
- Is CG Oncology (CGON) Pricing Reflect Its Recent 131% Surge And Cancer Breakthrough Hopes [Yahoo! Finance]Yahoo! Finance
- CG Oncology Conference: Credo Posts 75.5% CR in BOND-003, BLA Filing Targeted for 2026 [Yahoo! Finance]Yahoo! Finance
- H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating [Yahoo! Finance]Yahoo! Finance
- CG Oncology GAAP EPS of -$2.08 beats by $0.09, revenue of $4.04M beats by $1.24M [Seeking Alpha]Seeking Alpha
- CG Oncology (CGON) had its price target raised by HC Wainwright from $75.00 to $80.00. They now have a "buy" rating on the stock.MarketBeat
CGON
Earnings
- 11/14/25 - In-Line
CGON
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/17/26 - Form 4
- 3/13/26 - Form 4
- CGON's page on the SEC website